MONTVALE, N.J., April 14 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. , a biopharmaceutical company, today announced that they will host an R&D Day on Friday, April 21st, at 8.30 a.m. E.T., at the W New York Hotel in New York City.
Interested parties may access a live webcast of the presentation and accompanying slides by visiting the Investor Relations section of Memory Pharmaceuticals' website at http://www.memorypharma.com. An archived version of the webcast will be available at the same location through April 28, 2006.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.CONTACT: Jzaneen Lalani, Vice President, Legal Affairs of MemoryPharmaceuticals Corp., +1-201-802-7249, or Laura Perry of Stern InvestorRelations, Inc., +1-212-362-1200, for Memory Pharmaceuticals Corp.
